Stay updated on the most recent developments in Symeres.
Impurity synthesis at Symeres
Symeres has dedicated chemists to synthesize reference standards for our clients operating in (CMC) and GMP production.
Electrochemistry at Symeres
Discover the power of electrochemistry in synthesizing complex molecules and novel pharmaceutical structures.
Positron Emission Tomography at Symeres
Symeres has long-standing expertise in the design and synthesis of a wide variety of precursors to be used for positron emission tomography (PET).
Stable Isotope-Labeled Compounds at Symeres
Symeres has synthesized hundreds of stable isotope-labeled compounds with our clients in the last decades and can assist you with your needs.
Symeres welcomes Karen Damian to the team
Introducing our new director of Business Development
Amino acid synthesis at Symeres
The biocatalysis toolbox at Symeres enables efficient access to a wide range of multifunctional, optically pure, unnatural amino acids and their derivatives.
Peptidomimetics at Symeres
Macrocyclization of linear peptides is shown to be an effective way to overcome some of the shortcomings of peptide-based drug leads
π-Facial selectivity in the Diels–Alder reaction of glucosamine-based chiral furans and maleimides
Accessing novel chemical space by using carbohydrates as sustainable chiral starting materials for library synthesis.
Lipid chemistry at Symeres
Symeres has been supporting the global pharma and biotech industry with the synthesis and (ultra)-purification of these novel lipids. With the acquisition of Organix, we have significantly potentiated the platform.